Drug Shortage Report for APO-RANITIDINE

Last updated on 2019-04-05 History
Report ID 75626
Drug Identification Number 02280833
Brand name APO-RANITIDINE
Common or Proper name RANITITDINE
Company Name APOTEX INC
Active Ingredient(s) RANITIDINE
Strength(s) 15MG
Dosage form(s) SOLUTION
Route of administration ORAL
Packaging size 300ML
ATC code A02BA
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-02-11
Estimated end date 2019-04-05
Actual end date 2019-04-04
Shortage status Resolved
Updated date 2019-04-05
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-04-05 French Compare
v7 2019-04-05 English Compare
v6 2019-03-26 French Compare
v5 2019-03-26 English Compare
v4 2019-03-21 French Compare
v3 2019-03-21 English Compare
v2 2019-02-13 French Compare
v1 2019-02-13 English Compare